The board of directors of China Regenerative Medicine International Limited announced that with effect from 9 July 2020, Mr. Wang Xuejun ("Mr. Wang"), has tendered his resignation as (i) an execute Director; (ii) the authorized representative of the Company (the "Authorized Representative"), with effect from 9 July 2020 due to his decision to focus his time and effort on his other business. Following the resignation of Mr. Wang, the Board further announces that Mr. Qiu Bin, an executive Director, be appointed as the Authorized Representative and the Compliance Officer with effect from 9 July 2020.